CN Patent

CN101553242A — 促红细胞生成素受体肽制剂和用途

Assigned to Affymax Inc · Expires 2009-10-07 · 17y expired

What this patent protects

本发明涉及为促红细胞生成素受体(EPO－R)激动剂的肽化合物。本发明也涉及使用此类肽化合物治疗与血红细胞生产不足或缺陷相关的疾病的治疗方法。也提供了包含本发明的肽化合物的药物组合物和剂量。

USPTO Abstract

本发明涉及为促红细胞生成素受体(EPO－R)激动剂的肽化合物。本发明也涉及使用此类肽化合物治疗与血红细胞生产不足或缺陷相关的疾病的治疗方法。也提供了包含本发明的肽化合物的药物组合物和剂量。

Drugs covered by this patent

Patent Metadata

Patent number
CN101553242A
Jurisdiction
CN
Classification
—
Expires
2009-10-07
Drug substance claim
No
Drug product claim
No
Assignee
Affymax Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.